AU2002352420A1 - Pyrazine compounds and pharmaceutical compositions containing them - Google Patents
Pyrazine compounds and pharmaceutical compositions containing themInfo
- Publication number
- AU2002352420A1 AU2002352420A1 AU2002352420A AU2002352420A AU2002352420A1 AU 2002352420 A1 AU2002352420 A1 AU 2002352420A1 AU 2002352420 A AU2002352420 A AU 2002352420A AU 2002352420 A AU2002352420 A AU 2002352420A AU 2002352420 A1 AU2002352420 A1 AU 2002352420A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- pyrazine compounds
- pyrazine
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0104332-2 | 2001-12-19 | ||
| SE0104332A SE0104332D0 (en) | 2001-12-19 | 2001-12-19 | Therapeutic agents |
| PCT/GB2002/005736 WO2003051850A1 (en) | 2001-12-19 | 2002-12-18 | Pyrazine compounds and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002352420A1 true AU2002352420A1 (en) | 2003-06-30 |
Family
ID=20286431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002352420A Abandoned AU2002352420A1 (en) | 2001-12-19 | 2002-12-18 | Pyrazine compounds and pharmaceutical compositions containing them |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU2002352420A1 (en) |
| SE (1) | SE0104332D0 (en) |
| TW (1) | TW200410693A (en) |
| WO (1) | WO2003051850A1 (en) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005531520A (en) | 2002-03-28 | 2005-10-20 | メルク エンド カムパニー インコーポレーテッド | Substituted 2,3-diphenylpyridines |
| GB0216700D0 (en) | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| AU2003275242B2 (en) | 2002-09-27 | 2010-03-04 | Merck Sharp & Dohme Corp. | Substituted pyrimidines |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| GB0302673D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
| US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| US20060135523A1 (en) * | 2003-06-18 | 2006-06-22 | Astrazeneca Ab | 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| GB0314049D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314057D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314261D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| US7276608B2 (en) | 2003-07-11 | 2007-10-02 | Bristol-Myers Squibb Company | Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| US7326706B2 (en) | 2003-08-15 | 2008-02-05 | Bristol-Myers Squibb Company | Pyrazine modulators of cannabinoid receptors |
| US7517900B2 (en) | 2003-10-10 | 2009-04-14 | Bristol-Myers Squibb Company | Pyrazole derivatives as cannabinoid receptor modulators |
| JP4436369B2 (en) | 2004-01-28 | 2010-03-24 | エフ．ホフマン−ラ ロシュ アーゲー | Spiro-benzodioxoles and their use as CB1 antagonists |
| EP2305352A1 (en) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
| TW200602314A (en) | 2004-05-28 | 2006-01-16 | Tanabe Seiyaku Co | A novel pyrrolidine compound and a process for preparing the same |
| AU2005304039A1 (en) | 2004-11-09 | 2006-05-18 | F. Hoffmann-La Roche Ag | Dibenzosuberone derivatives |
| MX2007012213A (en) | 2005-04-06 | 2007-12-10 | Hoffmann La Roche | Pyridine-3-carboxamide derivatives as cb1 inverse agonists. |
| WO2006113704A2 (en) * | 2005-04-18 | 2006-10-26 | Neurogen Corporation | Subtituted heteroaryl cb1 antagonists |
| NZ564759A (en) | 2005-06-30 | 2011-08-26 | Prosidion Ltd | GPCR agonists |
| JP2009528266A (en) * | 2006-01-18 | 2009-08-06 | シェーリング コーポレイション | Cannabinoid receptor modifier |
| US7629346B2 (en) * | 2006-06-19 | 2009-12-08 | Hoffmann-La Roche Inc. | Pyrazinecarboxamide derivatives as CB1 antagonists |
| FR2904827B1 (en) | 2006-08-11 | 2008-09-19 | Sanofi Aventis Sa | 5,6-BISARYL-2-PYRIDINE CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE AS UROTENSIN II RECEPTOR ANTIGANISTS |
| US7781593B2 (en) | 2006-09-14 | 2010-08-24 | Hoffmann-La Roche Inc. | 5-phenyl-nicotinamide derivatives |
| KR101107896B1 (en) | 2006-10-04 | 2012-01-25 | 에프. 호프만-라 로슈 아게 | 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |
| AR064736A1 (en) | 2007-01-04 | 2009-04-22 | Prosidion Ltd | GPCR AGONISTS |
| ATE523507T1 (en) | 2007-01-04 | 2011-09-15 | Prosidion Ltd | PIPERIDINE GPCR AGONISTS |
| GB0700122D0 (en) | 2007-01-04 | 2007-02-14 | Prosidion Ltd | GPCR agonists |
| PE20081659A1 (en) | 2007-01-04 | 2008-10-24 | Prosidion Ltd | GPCR AGONISTS |
| EA016507B1 (en) | 2007-01-04 | 2012-05-30 | Прозидион Лимитед | Piperidine gpcr agonists |
| GB0720389D0 (en) | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
| GB0720390D0 (en) | 2007-10-18 | 2007-11-28 | Prosidion Ltd | G-Protein coupled receptor agonists |
| FR2927330B1 (en) * | 2008-02-07 | 2010-02-19 | Sanofi Aventis | 5,6-BISARYL-2-PYRIDINE CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE AS ANTAGONISTS OF UROTENSIN II RECEPTORS |
| WO2012031817A1 (en) * | 2010-09-09 | 2012-03-15 | F. Hoffmann-La Roche Ag | Determination of abca1 protein levels in cells |
| US8410107B2 (en) | 2010-10-15 | 2013-04-02 | Hoffmann-La Roche Inc. | N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| US8669254B2 (en) | 2010-12-15 | 2014-03-11 | Hoffman-La Roche Inc. | Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0397859A4 (en) * | 1987-11-12 | 1990-12-19 | Terumo Kabushiki Kaisha | Pyrazine derivatives and medicinal preparation containing same |
| WO1992002513A1 (en) * | 1990-08-06 | 1992-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic compounds |
-
2001
- 2001-12-19 SE SE0104332A patent/SE0104332D0/en unknown
-
2002
- 2002-12-18 AU AU2002352420A patent/AU2002352420A1/en not_active Abandoned
- 2002-12-18 WO PCT/GB2002/005736 patent/WO2003051850A1/en not_active Application Discontinuation
- 2002-12-19 TW TW091136670A patent/TW200410693A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200410693A (en) | 2004-07-01 |
| WO2003051850A1 (en) | 2003-06-26 |
| SE0104332D0 (en) | 2001-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002352420A1 (en) | Pyrazine compounds and pharmaceutical compositions containing them | |
| AU2002335536A1 (en) | Pyrimidine compound and medicinal composition thereof | |
| AU2002306269A1 (en) | N-arylphenylacetamide derivatives and pharmaceutical composition containing the same | |
| AU2002313236A1 (en) | Medicinal compositions | |
| IL157731A0 (en) | Caboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| HUP0400974A3 (en) | Peptide-based compounds and pharmaceutical compositions containing them | |
| HUP0401950A3 (en) | Pyrimidine derivatives and pharmaceutical compositions containing that compounds | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| IL158044A0 (en) | Cyclopropylindole derivatives and pharmaceutical compositions containing the same | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| IL158671A0 (en) | Benzyloxy derivatives and pharmaceutical compositions containing the same | |
| AU2002258221A1 (en) | Medicinal composition | |
| AU2002360117A1 (en) | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | |
| AU2002252981A1 (en) | Pharmaceutical compositions containing beta-mimetic agents and having few side-effects | |
| AU2002246659A1 (en) | Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds | |
| AU2001274171A1 (en) | Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof | |
| AU2002246658A1 (en) | Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds | |
| AU2002354460A1 (en) | Medicinal composition | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2002346223A1 (en) | Medicinal compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |